These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33357571)

  • 1. Subcutaneous Implantable Cardioverter-Defibrillators in Pediatrics and Congenital Heart Disease: A Pediatric and Congenital Electrophysiology Society Multicenter Review.
    von Alvensleben JC; Dechert B; Bradley DJ; Fish FA; Moore JP; Pilcher TA; Escudero C; Ceresnak SR; Kwok SY; Balaji S; Aziz PF; Papagiannis J; Cortez D; Garnreiter J; Kean A; Schäfer M; Collins KK
    JACC Clin Electrophysiol; 2020 Dec; 6(14):1752-1761. PubMed ID: 33357571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inappropriate ICD shocks in pediatrics and congenital heart disease patients: Risk factors and programming strategies.
    Garnreiter JM; Pilcher TA; Etheridge SP; Saarel EV
    Heart Rhythm; 2015 May; 12(5):937-42. PubMed ID: 25620047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients.
    Berul CI; Van Hare GF; Kertesz NJ; Dubin AM; Cecchin F; Collins KK; Cannon BC; Alexander ME; Triedman JK; Walsh EP; Friedman RA
    J Am Coll Cardiol; 2008 Apr; 51(17):1685-91. PubMed ID: 18436121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcutaneous Implantable Cardioverter Defibrillators in Pediatrics and Congenital Heart Disease.
    Kohli U; von Alvensleben J; Srinivasan C
    Card Electrophysiol Clin; 2023 Dec; 15(4S):e1-e16. PubMed ID: 38030336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcutaneous Implantable Cardioverter-Defibrillators in Patients With Congenital Heart Disease.
    Waldmann V; Marquié C; Bessière F; Perrot D; Anselme F; Badenco N; Barra S; Bertaux G; Blangy H; Bordachar P; Boveda S; Chauvin M; Clémenty N; Clerici G; Combes N; Defaye P; Deharo JC; Durand P; Duthoit G; Eschalier R; Fauchier L; Garcia R; Geoffroy O; Gitenay E; Gourraud JB; Guenancia C; Iserin L; Jacon P; Jesel-Morel L; Kerkouri F; Klug D; Koutbi L; Labombarda F; Ladouceur M; Laurent G; Leclercq C; Maille B; Maltret A; Massoulié G; Mondoly P; Ninni S; Ollitrault P; Pasquié JL; Pierre B; Pujadas P; Champ-Rigot L; Sacher F; Sadoul N; Schatz A; Winum P; Milliez PU; Probst V; Marijon E
    J Am Coll Cardiol; 2023 Aug; 82(7):590-599. PubMed ID: 37558371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased inappropriate shocks with new generation ICDs in children and patients with congenital heart disease.
    Goldstein SA; LaPage MJ; Dechert BE; Serwer GA; Yu S; Lowery RE; Bradley DJ
    Congenit Heart Dis; 2018 May; 13(3):413-418. PubMed ID: 29372620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter experience with novel implantable cardioverter defibrillator configurations in the pediatric and congenital heart disease population.
    Stephenson EA; Batra AS; Knilans TK; Gow RM; Gradaus R; Balaji S; Dubin AM; Rhee EK; Ro PS; Thøgersen AM; Cecchin F; Triedman JK; Walsh EP; Berul CI
    J Cardiovasc Electrophysiol; 2006 Jan; 17(1):41-6. PubMed ID: 16426398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Midterm Results of Implantable Cardioverter Defibrillators in Children and Young Adults from a Single Center in Turkey.
    Aykan HH; Karagoz T; Gulgun M; Ertugrul I; Aypar E; Ozer S; Alehan D; Celiker A; Ozkutlu S
    Pacing Clin Electrophysiol; 2016 Nov; 39(11):1225-1239. PubMed ID: 27620455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. System survival of nontransvenous implantable cardioverter-defibrillators compared to transvenous implantable cardioverter-defibrillators in pediatric and congenital heart disease patients.
    Radbill AE; Triedman JK; Berul CI; Fynn-Thompson F; Atallah J; Alexander ME; Walsh EP; Cecchin F
    Heart Rhythm; 2010; 7(2):193-8. PubMed ID: 20022820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of implantable cardioverter-defibrillators in pediatric patients awaiting heart transplantation.
    Dubin AM; Berul CI; Bevilacqua LM; Collins KK; Etheridge SP; Fenrich AL; Friedman RA; Hamilton RM; Schaffer MS; Shah M; Silka MJ; Van Hare GF; Kertesz NJ
    J Card Fail; 2003 Oct; 9(5):375-9. PubMed ID: 14583898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-center experience with implantable cardioverter-defibrillators in adults with complex congenital heart disease.
    Khanna AD; Warnes CA; Phillips SD; Lin G; Brady PA
    Am J Cardiol; 2011 Sep; 108(5):729-34. PubMed ID: 21684513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implant and Midterm Outcomes of the Subcutaneous Implantable Cardioverter-Defibrillator Registry: The EFFORTLESS Study.
    Boersma L; Barr C; Knops R; Theuns D; Eckardt L; Neuzil P; Scholten M; Hood M; Kuschyk J; Jones P; Duffy E; Husby M; Stein K; Lambiase PD;
    J Am Coll Cardiol; 2017 Aug; 70(7):830-841. PubMed ID: 28797351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Experience With the Subcutaneous Implantable Cardioverter-Defibrillator in Adults With Congenital Heart Disease.
    Moore JP; Mondésert B; Lloyd MS; Cook SC; Zaidi AN; Pass RH; John AS; Fish FA; Shannon KM; Aboulhosn JA; Khairy P;
    Circ Arrhythm Electrophysiol; 2016 Sep; 9(9):. PubMed ID: 27635073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantable cardioverter defibrillator therapy in adults with congenital heart disease: who is at risk of shocks?
    Koyak Z; de Groot JR; Van Gelder IC; Bouma BJ; van Dessel PF; Budts W; van Erven L; van Dijk AP; Wilde AA; Pieper PG; Sieswerda GT; Mulder BJ
    Circ Arrhythm Electrophysiol; 2012 Feb; 5(1):101-10. PubMed ID: 22095638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcutaneous implantable cardioverter defibrillators in children, young adults and patients with congenital heart disease.
    Bordachar P; Marquié C; Pospiech T; Pasquié JL; Jalal Z; Haissaguerre M; Thambo JB
    Int J Cardiol; 2016 Jan; 203():251-8. PubMed ID: 26519678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantable cardioverter defibrillator therapy for prevention of sudden cardiac death in children in the Netherlands.
    Heersche JH; Blom NA; van de Heuvel F; Blank C; Reimer AG; Clur SA; Witsenburg M; ten Harkel AD
    Pacing Clin Electrophysiol; 2010 Feb; 33(2):179-85. PubMed ID: 20025697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Experience With the Subcutaneous Implantable Cardioverter-Defibrillator in Teenagers and Young Adults.
    Bettin M; Larbig R; Rath B; Fischer A; Frommeyer G; Reinke F; Köbe J; Eckardt L
    JACC Clin Electrophysiol; 2017 Dec; 3(13):1499-1506. PubMed ID: 29759830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience of subcutaneous and transvenous implantable cardioverter defibrillators in children and teenagers.
    Pettit SJ; McLean A; Colquhoun I; Connelly D; McLeod K
    Pacing Clin Electrophysiol; 2013 Dec; 36(12):1532-8. PubMed ID: 24033753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Clinical Outcomes of Subcutaneous Versus Transvenous Implantable Defibrillator Therapy.
    Brouwer TF; Yilmaz D; Lindeboom R; Buiten MS; Olde Nordkamp LR; Schalij MJ; Wilde AA; van Erven L; Knops RE
    J Am Coll Cardiol; 2016 Nov; 68(19):2047-2055. PubMed ID: 27810043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies.
    Brouwer TF; Knops RE; Kutyifa V; Barr C; Mondésert B; Boersma LVA; Lambiase PD; Wold N; Jones PW; Healey JS
    Europace; 2018 Sep; 20(FI2):f240-f248. PubMed ID: 29771327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.